Becton Dickinson (BDX) EBITDA (2009 - 2026)
Becton Dickinson's (BDX) quarterly EBITDA came in at $663.0 million in Q2 2026, down 10.28% year-over-year from $739.0 million in Q2 2025, and up 612.9% quarter-over-quarter from $93.0 million in Q1 2026.
Analysis
Becton Dickinson (BDX) EBITDA (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported EBITDA for 18 consecutive years, with $663.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA fell 10.28% year-over-year to $663.0 million in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 12.97% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 7.59% from the prior year.
- EBITDA was $663.0 million for Q2 2026 at Becton Dickinson, up from $93.0 million in the prior quarter.
- Over five years, EBITDA peaked at $1.2 billion in Q3 2025 and troughed at $93.0 million in Q1 2026.
- A 5-year average of $564.2 million and a median of $558.0 million in 2022 frame the typical range for EBITDA.
- Across the five-year window, EBITDA soared 88.75% in 2025 and sank 75.72% in 2026, its largest moves.
- Over 5 years, EBITDA stood at $585.0 million in 2022, then fell by 24.96% to $439.0 million in 2023, then advanced by 3.19% to $453.0 million in 2024, then gained by 21.85% to $552.0 million in 2025, then grew by 20.11% to $663.0 million in 2026.
- The last three EBITDA figures came in at $663.0 million (Q2 2026), $93.0 million (Q1 2026), and $552.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 663.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 395.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 179.10 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 217.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 45.39 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 6.83 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -1.06 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -5.15 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | -166,850.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 663.00 Mn |
| Mar 31, 2026 | 93.00 Mn |
| Dec 31, 2025 | 552.00 Mn |
| Sep 30, 2025 | 1.17 Bn |
| Jun 30, 2025 | 739.00 Mn |
| Mar 31, 2025 | 383.00 Mn |
| Dec 31, 2024 | 453.00 Mn |
| Sep 30, 2024 | 622.00 Mn |
| Jun 30, 2024 | 602.00 Mn |
| Mar 31, 2024 | 734.00 Mn |
| Dec 31, 2023 | 439.00 Mn |
| Sep 30, 2023 | 349.00 Mn |
| Jun 30, 2023 | 549.00 Mn |
| Mar 31, 2023 | 628.00 Mn |
| Dec 31, 2022 | 585.00 Mn |
| Sep 30, 2022 | 489.00 Mn |
| Jun 30, 2022 | 537.00 Mn |
| Mar 31, 2022 | 564.00 Mn |
| Dec 31, 2021 | 692.00 Mn |
| Sep 30, 2021 | 380.00 Mn |